Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories orders, deals and press releases
81 filed, newest first. Page 2 of 2.
Jan 2015
Jul 2014
9 Jul · Business
Mar 2014
10 Mar · Business
As required under Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, the Compensation Committee of the Board of Directors of the Company in its meeting held on March 08, 2014 has granted 2,25,000/- (Two Lac Twenty Five Thousand) equity shares to the Employees of the Company in terms of its Employee Stock Option Scheme - 2008.Against each option, the grantee will have a right to apply for and get allotted one equity share at an exercise price of Rs. 46/- (Rupees Forty Six Only). The vesting period for the said option is a graded manner over five years as prescribed in the approved existing Scheme.
Jan 2014
8 Jan · Business
Board has approved allotment of 7,600 equity shares through circular resolution on January 08, 2014 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2004 & Employee Stock Option Scheme 2008 of the Company.
Oct 2013
24 Oct · Business
Board of Directors in its meeting held on October 19, 2013 allotted and issued 10,625 equity shares of Rs. 2/-each pursuant to exercise of the stock options by the eligible employees under the Employees Stock Option Scheme 2008 of the Company.8 Oct · Business
Board has approved allotment of 16,375 equity shares through circular resolution on September 19, 2013 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.
Jul 2013
11 Jul · Business
Board has approved allotment of 11,250 equity shares through circular resolution on July 06, 2013 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.
May 2013
Jan 2013
Nov 2012
Oct 2012
Jul 2012
18 Jul · Business
Vide letter dated July 17, 2012 that the Hon'ble High Court Bombay vide its order dated July 12, 2012 approved the Scheme of Arrangement between AVM Capital Services Private Limited ('ACSPL') and Chevy Capital Services Private Limited ('CCSPL') and PM Capital Services Private Limited ('PCSPL') and Pranit Trading Private Limited ('PTPL') and Viramrut Trading Private Limited ('VTPL') and Unichem Laboratories Limited ('ULL') and their respective shareholders under Section 391 to 394 read with Sections 80, 100 to 103 and any other applicable provisions of the Companies Act, 1956 ('Scheme' or 'the Scheme').
May 2012
12 May · Business
Board of Directors in its meeting held on May 12, 2012 inter alia allotted and issued 10,500 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.
Oct 2011
Jun 2011
24 Jun · Business
Board of Directors of the Company in its meeting held on June 24, 2011 inter alia, allotted and issued 48,376 equity shares of Rs.2/- each pursuant to the exercise of the stock options by eligible employees under the Employee Stock Option Scheme - 2008 of the Company.
Apr 2011
18 Apr · Business
Board of Directors of the Company in its meeting held on April 16, 2011 inter alia, allotted and issued 7,500 equity shares of Rs.2/- each pursuant to the exercise of the stock options by Non-executive Independent Directors under the Employee Stock Option Scheme-2008 of the Company.
Jan 2011
17 Jan · Business
Board of Directors in its meeting held on January 15, 2011 inter alia, considered the following: Allotted and issued 3,750 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.
Oct 2010
18 Oct · Business
Board of Directors in its Board Meeting held on October 16, 2010 allotted and issued 2,300 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company. The said shares will be issued prior to Company's record date October 22, 2010 kept for split and interim dividend.
May 2010
11 May · Business
Board of Directors of the Company at its Meeting held on May 10, 2010, allotted and issued 2,800 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company.10 May · Business
Board of Directors of the Company at its Meeting held on May 10, 2010, allotted and issued 3,000 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme-2008 of the Company.
Dec 2009
4 Dec · Business
Press release dated December 4, 2009, titled " NICHE GENERICS LIMITED, the wholly owned subsidiary of Unichem Laboratories receives Marketing Authorizations for 'Anastrozole' ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
28 Aug · Business
Press release dated August 27, 2009, titled "Unichem Laboratories receives ANDA approval from USFDA for CLONIDINE HYDROCHLORIDE TABLETS". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.